Saturday 17 October 2026
Export ARDT’s income statement to Excel — free account
Ardent Health, Inc.
ARDT Healthcare Medical Care Facilities
Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024. In the quarter to June 2026, revenue fell 1.40%, EPS fell 76.9%, free cash flow grew 121.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
11.95
0.25
−2.05%
Follow ARDT
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 7 | 6 |
P/E ratio |
11.06 | 11.06 | 11.06 | 9.97 | 9.10 |
Altman Z-Score |
— | — | — | 2.19 | 1.97 |
P/S ratio |
0.36 | 0.36 | 0.36 | 0.38 | 0.20 |
P/FCF ratio |
17.36 | 17.36 | 17.36 | 17.74 | 4.81 |
Altman Z″-Score (non-manufacturers) |
— | 1.60 | 1.60 | 2.43 | 2.47 |
P/Operating CF |
16.82 | 16.82 | 16.82 | 18.92 | 5.56 |
Beneish M-Score |
— | — | (2.35) | (2.51) | (2.77) |
P/B ratio |
1.75 | 1.75 | 1.75 | 1.49 | 0.74 |
Price to Tangible BV |
8.80 | 8.80 | 8.80 | 3.82 | 1.73 |
EV/Sales |
0.49 | 0.49 | 0.49 | 0.47 | 0.26 |
EV/EBITDA |
6.32 | 6.32 | 6.32 | 5.02 | 3.36 |
EV/Operating CF |
10.63 | 10.63 | 10.63 | 8.89 | 3.47 |
EV/FCF |
23.86 | 23.86 | 23.86 | 21.96 | 6.31 |
Quick Ratio |
— | 1.31 | 1.22 | 1.37 | 1.33 |
Current Ratio |
— | 1.74 | 1.63 | 1.94 | 1.97 |
Net Debt/EBITDA |
0.00 | 2.00 | 2.02 | 0.97 | 0.80 |
Debt/Assets |
0.00% | 26.30% | 25.08% | 22.10% | 20.78% |
Debt/Equity |
0.00 | 1.13 | 1.10 | 0.72 | 0.65 |
Asset Turnover |
0.00 | 2.29 | 1.17 | 1.23 | 1.23 |
Operating CF/Net income |
0.95 | (0.20) | 4.11 | 1.50 | 3.46 |
Capex/Depreciation |
(0.94) | (1.05) | (0.94) | (1.24) | (1.32) |
Interest Coverage |
4.65 | 2.65 | 3.02 | 6.19 | 5.90 |
| 0.00% | 0.00% | 5.10% | 16.20% | 8.47% | |
| 0.00% | 8.44% | 1.17% | 4.34% | 2.65% | |
ROIC |
0.00% | 7.70% | 7.68% | 12.31% | 9.80% |
Return on Tangible Assets |
0.00% | 13.60% | 3.76% | 12.02% | 6.97% |
Average Days of Receivables |
0.00 | 42.93 | 52.32 | 45.46 | 39.60 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
78.83% | 79.99% | 80.56% | 78.19% | 78.00% |
Intangible Assets out of Total Assets |
0.00 | 0.21 | 0.19 | 0.19 | 0.18 |
Share Based Compensation of Revenue |
0.01% | 0.01% | 0.02% | 0.30% | 0.62% |
Graham Net Nets |
(0.96) | (0.96) | (0.96) | (0.71) | (1.24) |
Graham Number |
0.00 | 0.00 | 0.00 | 21.04 | 16.17 |
Earnings Yield |
9.04% | 9.04% | 9.04% | 10.03% | 10.99% |
Free Cash Flow Yield |
5.76% | 5.76% | 5.76% | 5.64% | 20.81% |
Revenue per Share |
0.00 | 40.67 | 42.89 | 45.05 | 44.93 |
Operating CF per Share |
0.00 | (0.30) | 1.76 | 2.38 | 3.34 |
Capex per Share |
0.00 | (1.20) | (1.09) | (1.42) | (1.51) |
Free Cash Flow per Share |
0.00 | (1.50) | 0.67 | 0.96 | 1.84 |
Cash per Share |
— | 3.62 | 3.47 | 4.20 | 5.04 |
Shareholders Equity per Share |
0.00 | 8.24 | 8.52 | 11.49 | 11.98 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 8.24 | 8.52 | 11.49 | 11.98 |
Free Cash Flow |
11.46 | (189.47) | 84.29 | 127.52 | 258.61 |
Working Capital |
— | 600.65 | 623.98 | 887.33 | 1,012.28 |
Capital Expenditures |
(135.44) | (151.11) | (137.41) | (187.51) | (211.90) |
Net Current Asset Value |
0.00 | (2,030.08) | (2,038.46) | (1,602.15) | (1,545.17) |
EV/EBIT |
8.47 | 8.47 | 8.47 | 6.90 | 5.01 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
6.16 | 6.16 | 6.16 | 5.57 | 3.82 |
| Other line items | |||||
Depreciation/Fixed assets |
0.00 | 0.18 | 0.18 | 0.18 | 0.17 |
Cash ROIC |
0.00% | (7.09%) | 3.12% | 4.02% | 7.40% |
Accounts Receivable Turnover |
0.00 | 0.00 | 7.85 | 7.86 | 8.85 |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 689.41 | 759.24 | 714.57 |
Average Payables |
— | — | 397.67 | 437.90 | 429.59 |
Average Inventory |
— | — | 106.32 | 110.29 | 116.84 |
Average Assets |
— | 2,239.42 | 4,605.20 | 4,843.83 | 5,123.15 |
Average Common Equity |
— | — | 1,057.26 | 1,298.11 | 1,603.71 |
Columns are period end dates